Test Price
1,200 AED✅ Home Collection Available
HLA DNA High Resolution Typing – DRB1 Locus Test in UAE
Executive Summary & Core Metrics
This test provides 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139). It includes temperature-controlled cold-chain home collection, VIP mobile phlebotomy, telephonic post-test clinical guidance, and direct billing verification via WhatsApp at +971 54 548 8731.
- ✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- ✓Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily 8 AM–11 PM).
- ✓Clinical Guidance: Telephonic Post-Test Guidance for professional result interpretation.
- ✓Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The HLA DNA High Resolution Typing – DRB1 Locus Test determines precise allele variants of the human leukocyte antigen DRB1 gene, critical for organ and bone marrow transplantation compatibility, autoimmune disease risk assessment, and pharmacogenomic profiling. This advanced molecular assay uses PCR-based DNA sequencing (Sanger/NGS) to deliver clinically actionable, allele-level results that significantly reduce graft rejection risk and improve personalized treatment plans.
| Feature | Our Test (High-Resolution DNA Sequencing) | Closest Alternative (Conventional Serological Typing) |
|---|---|---|
| Methodology | PCR-based DNA sequencing (Sanger/NGS) delivering allele-level resolution | Serological antigen detection; low resolution (broad serotype) |
| Precision | 99.9% diagnostic accuracy, identifies specific DRB1* alleles (e.g., *04:01) | Identifies only broad groups (e.g., DR4); cannot distinguish disease-associated subtypes |
| Turnaround Time | 10–12 working days | 5–7 days (but clinically less informative) |
| Sample Type | Blood (EDTA/ACD) or buccal swab; painless, refrigerated transport | Blood only |
| Clinical Utility | Transplantation matching, autoimmune risk (e.g., celiac, Type 1 diabetes), pharmacogenomics | Limited to basic donor screening; cannot inform personalized therapy |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I emphasize that HLA typing results provide critical guidance for transplant compatibility and autoimmune risk stratification. However, these results must always be interpreted in the context of your complete medical history and current medications. Never alter your treatment regimen without consulting your referring physician; your safety remains our paramount concern.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication Management
Do not discontinue or change any prescribed medication without explicit approval from your doctor. Modifying immunosuppressive or other therapies solely based on HLA test results may lead to serious health consequences.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Do not proceed with sample collection if you have a severe febrile illness, received a blood transfusion within the last 2 weeks, or are unable to provide informed consent.
- During/After Collection: If you experience fainting, persistent bleeding, chest pain, difficulty breathing, or swelling beyond the collection site, seek immediate emergency medical attention.
- Important: This test does not replace professional medical advice. Always report unusual symptoms to your doctor.
Patient FAQ & Clinical Guidance
1. What is HLA DRB1 high-resolution typing used for?
It uses DNA sequencing to precisely determine your HLA-DRB1 allele profile for transplant matching and autoimmune risk assessment.
2. How is the sample collected for this test?
A simple blood draw or buccal swab is taken by a certified phlebotomist at your home. The transport is temperature-controlled and secure.
3. Do I need to fast before the HLA DRB1 test?
No fasting or special preparation is needed; you can eat and drink normally before the draw.
UAE Regulatory & Data Privacy Adherence
This service adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and Federal Decree-Law No. 4 of 2016 on Medical Liability. Laboratory processing is ISO 9001:2015 certified (INT/EGQ/2509DA/3139). All clinical interpretations are governed by DHA and MOHAP regulations.
Clinical & Logistical Metadata
| Test Name | HLA DNA High Resolution Typing – DRB1 Locus |
| Price (AED) | 1,200 |
| Turnaround Time | 10–12 working days |
| Sample Type / Matrix | Blood (EDTA/ACD) or Buccal Swab; VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM–11 PM. |
| Methodology Used | PCR-based DNA Sequencing (Sanger/NGS) |
| ICD-10-CM Code | Z13.83 |
| LOINC Code | 86206-4 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians